Management of breast cancer with targeted agents: importance of heterogeneity. [corrected].

Nature Reviews. Clinical Oncology
Serena Di Cosimo, José Baselga

Abstract

Breast cancer is a heterogeneous disease with different molecular drivers regulating its growth, survival and response to therapy. Breast cancer is divided in three major subtypes based on the pattern of expression of hormone receptors and HER2: luminal tumors (or HR positive), HER2 amplified tumors, and the remaining subtypes being collectively referred to as triple-negative breast cancer. While tumors within these subtypes have similar gene-expression patterns, clinical outcomes, and response to therapy, this division is far from perfect and subgroups within these groups are beginning to be identified. In terms of therapy, an increasingly rational drug development effort has resulted in agents against new molecular targets that are active against only those tumors with the targeted molecular alteration or phenotype. These agents include receptor and non-receptor tyrosine kinase inhibitors (HER1, HER2, HER3, insulin-like growth factor receptor, c-met, fibroblast growth factor receptor and HSP 90 inhibitors), intracellular signaling pathways (PI3K, AKT, mTOR), angiogenesis inhibitors and agents that interfere with DNA repair (PARP inhibitors). Thus, the overall management of breast cancer will increasingly require an understand...Continue Reading

References

Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
Aug 30, 2000·Nature·C M PerouD Botstein
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J G KlijnUNKNOWN Combined Hormone Agents Trialists' Group and the European Organization for Research and Treatment of Cancer
Jun 5, 2001·Nature Reviews. Molecular Cell Biology·G S Martin
Jun 1, 2002·Science·Lewis C Cantley
Sep 12, 2002·Pharmacological Reviews·László Virág, Csaba Szabó
Apr 20, 2004·Cancer Cell·Matthew C FranklinMark X Sliwkowski
Jun 2, 2004·Nature Reviews. Cancer·Timothy J Yeatman
Oct 19, 2004·Oncogene·Paul A BromannSara A Courtneidge
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
Jun 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaFederico Rojo
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michele De LaurentiisSabino De Placido
Aug 16, 2005·Current Opinion in Cell Biology·Egle Avizienyte, Margaret C Frame
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman RouzierLajos Pusztai
Dec 31, 2005·The New England Journal of Medicine·UNKNOWN Breast International Group (BIG) 1-98 Collaborative GroupAron Goldhirsch
Sep 21, 2006·Journal of the National Cancer Institute·Davide MauriJohn P A Ioannidis
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa A CareyCharles M Perou
Apr 19, 2007·Journal of the National Cancer Institute·Maurizio ScaltritiJosé Baselga
Jul 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Camille HammondKaren L Syrjala
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva S ThomasHenri H Roché
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep TaberneroAimery de Gramont
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shanu ModiClifford A Hudis
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Mar 12, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep TaberneroJosé Baselga
Apr 19, 2008·The New England Journal of Medicine·Joseph A SparanoNancy E Davidson
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chia C PorteraSandra M Swain
Aug 5, 2008·Cancer Research·Katherine Stemke-HaleBryan T Hennessy
Nov 18, 2008·Cancer Research·Gail D Lewis PhillipsMark X Sliwkowski
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaSusan Galbraith
Jan 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander Paterson, Tom Baker

❮ Previous
Next ❯

Citations

Jul 25, 2012·Nature Reviews. Clinical Oncology·Karin BeelenSabine C Linn
Mar 26, 2013·Journal of Clinical Pathology·Ming LeePuay Hoon Tan
Oct 29, 2010·Journal of Hematology & Oncology·Rafael Santana-Davila, Edith A Perez
Feb 25, 2011·Breast Cancer Research : BCR·David I RodenhiserAnn F Chambers
May 5, 2012·Breast Cancer Research : BCR·Rosa NadalMaría José Serrano
May 9, 2012·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Tímea VáradiPeter Nagy
Feb 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M YiK K Hunt
May 24, 2012·Expert Opinion on Investigational Drugs·William J Gradishar
Dec 24, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria-Magdalena MocanuJános Szöllősi
Jul 4, 2012·Cytokine & Growth Factor Reviews·Hubert Hondermarck
Oct 19, 2010·Journal of Oncology·Adhemar Longatto FilhoFernando C Schmitt
Jul 21, 2011·Molecular Systems Biology·Adam L CohenAndrea H Bild
Apr 6, 2011·Journal of Cellular Physiology·Valentina CiravoloSerenella M Pupa
May 28, 2011·International Journal of Cancer. Journal International Du Cancer·Serena GermanoLorraine O'Driscoll
Apr 24, 2015·Science Translational Medicine·Oliver JonasRobert Langer
Sep 4, 2015·Nature·Tiffany Y-T HsuThomas F Westbrook
Jul 22, 2015·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Anbok LeeByung-In Moon
Feb 28, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ebubekir DiricanAyşe Özer
Jan 26, 2017·Expert Opinion on Investigational Drugs·Antonella De LucaNicola Normanno
Dec 3, 2014·Seminars in Oncology·Sumita TrivediRobert L Ferris
Apr 13, 2012·Translational Oncology·Carolina Sens-AbuázarDirce Maria Carraro
Mar 7, 2014·Experimental Biology and Medicine·Jing HuGengyin Zhou
Dec 26, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yunshan WangGuangwei Wei
Jan 1, 2012·Pharmaceuticals·Albert J ChangSuzanne Lapi
Sep 19, 2015·Breast Cancer : Basic and Clinical Research·Xin Jin, Ping Mu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

The New England Journal of Medicine
C Kent Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Antonio C WolffCollege of American Pathologists
JAMA : the Journal of the American Medical Association
Lisa A CareyRobert C Millikan
© 2021 Meta ULC. All rights reserved